Find clinical trials for Breast Cancer in Milano, Lombardia

adjuvant chemotherapy regimen in patients with early-stage luminal B breast cancer.The primary endpoint will be to evaluate the fea...

Breast cancer is the most common form of cancer among women. For patients candidated for adjuvant chemotherapy and endocri...

adjuvant systemic treatment instead of adjuvant chemotherapy followed by endocrine therapy in older patients with stage II-III ER+/HER2- early breast...

DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour activity of trastuzumab deruxtecan (T-DXd) in combination with o ...

-positive / HER2-negative breast cancer which has spread beyond the original tumor and/or to other organs.During this study, anti-h...

This study will be conducted in patients with metastatic breast cancer who have specific Fibroblast Growth Factor Receptor gene abn...

This program initially aims to recruit 1300 breast cancer patients from a large number of hospitals across Europe. Eligible patient...

This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...

to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...

This study to learn more about olaparib and olaparib plus durvalumab combination therapy and also to better understand the studied disease, breast...